Start-Up Stories: Buildouts and Growth

When: October 17, 2019, 11:30 am - 1:00 pm
Where: LabCentral, 700 Main Street, North, Cambridge, MA

Join us for our first installment of Start-Up Stories, a series based on real challenges the companies of LabCentral have faced. This installment: Buildouts and Growth.

“I’m unsure of all the moving pieces involved in relocating after LabCentral. I wish I had a magical sage to help set up permitting and necessary safety and lab systems documentation so we could get on with it. Is staying in Cambridge really that important? I got the wrong vendor who cannot do what I need! Now what? Which vendor/contractor services can I live without? How do I get through these communication and team culture growing pains while my team grows so rapidly?” We hear you! These questions all came from conversations with alumni companies during their transition out of LabCentral. We’re bringing those same alumni back to support current early-stage startups on the same questions we hear current residents pondering. Join us on October 17th for our first installment of Start-Up Stories, a series based on real challenges the companies of LabCentral have faced. This installment will focus on Buildouts and Growth and be moderated by current LabCentral 610 resident and LabCentral 700 alum, Kamran Tavangar, COO of Affinivax. Panelists include Bernat Ollie, COO of Vedanta Biosciences; Vipin Suri, Vice President of Obsidian Therapeutics; Kathryn Swiderski, Senior Manager, Facilities for Generation Bio; Thomas Schuetz, CEO and Co-Founder of Compass Therapeutics; and Ryan Chappel, Operations Manager of Platelet Biogenesis. The panel will cover topics like developing a growth and staffing strategy, picking a new home, coordinating a build, shifting company culture and much more!

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter